The Expanded Prostate Cancer Index Composite Sexual Function instrument and the University of California Los Angeles Prostate Cancer Index Sexual Function instrument capture gradations of both sexual and erectile function.
To describe practice patterns of primary care physicians (PCPs) for the diagnosis, treatment and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), the authors surveyed 556 PCPs in Boston, Chicago, and Los Angeles (RR=52%). Only 62% reported ever seeing a patient like the one described in the vignette. In all, 16% were 'not at all' familiar with CP/CPPS, and 48% were 'not at all' familiar with the National Institutes of Health classification scheme. PCPs reported practice patterns regarding CP/CPPS, which are not supported by evidence.
The National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) is a commonly used 13-item questionnaire for the assessment of symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Lower urinary tract dysfunction is a common and distressing problem. With functional, psychological, and social sequel, it can have far-reaching effects on everyday life for individuals affected and others.
This article details major initial findings from the Urologic Diseases in America project with respect to the demographic impact of the most common benign, malignant, and pediatric urologic conditions.
Major systemic barriers continue to limit the implementation of new evidence-based therapies to slow, stop, or reverse the progression of chronic kidney disease to ESRD at the level of the nephrology practice.
Prostatitis accounts for 2 million outpatient visits annually. Most cases fit the definition of chronic pelvic pain syndrome. Despite evidence that antibiotics are not effective for this syndrome, they were prescribed for 69% of these men.
The overall objective of the project, Urologic Diseases in America, is to quantify the burden of urologic diseases on the American public. Until this project, no authoritative omnibus had compiled a comprehensive set of data analyses that synthesized information available from myriad national and regional sources across the public and private sectors in the United States.
Although the data presented in this chapter focus on the direct medical costs of Interstitial cystitis (IC), patients are equally, if not more, affected by loss of work opportunities, effects on relationships, and overall diminished quality of life.